Genmab — April 2013
-
-
Zalutumumab ADC?
-
vrøvl. Zalutumumab in combination with radiotherapy and a radiosensitizing agent.
-
Hvorfor mon Dr Overgaard har brug for sådan et patent kort før Dahanca resultater?
-
Z: hate
-
Hexabody kan vel ikke katagoriseres som radiosensitizing agent vel?
-
indsent i december .jvorfor gør man det i et stof man har opgivet?
-
Jens Overgaard er ansvarlig på Da
hanca 19 -
Radiosenstizer: Any substance that makes tumor cells easier to kill with radiation therapy. Some radiosensitizers are being studied in the treatment of cancer. Also called radiosensitizing agent.
-
Nej, tror ikke zalu falder i den kategori
-
selvom det er et godt stof
-
men gør Hexabody? nej vel
-
hexa gør noget med bindingsmekanismen på molekylen og har vel intet at gøre med kemo
-
http://www.blogtalkradio.com/curepanel/2013/04/25/dr-robert-orlowski-on-the-cure-panel-talk-show-episode-10 afvent et minut før indlægget starter - myeloma update
-
-
Gentogen thumps up for alle de oplysninger du graver frem. Det er imponerende
-
Hej Andreas
Ansøgningen er ganske vist indleveret i december 2012, men er en fortsættelse af en tidliere ansøgning med prioritet helt tilbage fra juni 2007. Dvs det er ikke en ny ansøgning. Vi har valgt at holde denne ansøgning i live, da vi ’tager telefon’ hvis nogen ringer om muligheder at udliscentere produktet.)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind